Acquired psychiatric disorder decisions — 2025

The Board granted an effective date of July 12, 2023, for a 100 percent rating for schizophrenia and a separate TDIU from December 28, 2022 until prior to July 12, 2023.

The Board granted service connection for varicose veins in the bilateral lower extremities and dismissed the appeal for an acquired psychiatric disorder due to untimely notice of disagreement. The lumbar spine disability claim was remanded for further development.

The Board granted service connection for cirrhosis, hepatitis C, hepatocellular carcinoma, gastroesophageal reflux disease (GERD), gastritis, Barrett's esophagus, and obstructive sleep apnea but dismissed the claim for an acquired psychiatric disability.

The Board denied service connection for an acquired psychiatric disorder, specifically major depressive disorder with anxiety, as the condition clearly and unmistakably existed prior to active duty and was not aggravated during service.

The Board granted service connection for an acquired psychiatric disability, finding that the evidence supports a direct link to the Veteran's active duty service.

The Board denied service connection for various disabilities, including an acquired psychiatric disability, headaches, a back disability, heart disability, and residuals of a stroke, as the evidence did not support a finding that these conditions were related to the Veteran's active service or caused by his service-connected left ear disabilities.

The appeal was denied for service connection of a cervical spine disorder, and several claims were remanded for further development.

The Board granted service connection for essential tremor and an acquired psychiatric disorder, to include anxiety, both related to herbicide exposure during the Veteran's active duty service.

The Board denied service connection for an acquired psychiatric disorder, chronic rhinitis, and obstructive sleep apnea. The headache claim was remanded for further examination.

The Board granted service connection for bladder cancer, diabetes mellitus, type 2, and an acquired psychiatric disability (unspecified depressive disorder), but denied a compensable rating for bilateral hearing loss.

The Board denied service connection for various conditions and a TDIU, as the evidence did not support a finding that any of these disabilities were related to the Veteran's military service.

The Board denied the veteran's claims for service connection and increased ratings, finding that the evidence did not support an increase in disability or a link to service.

The Board granted a 70 percent rating for an acquired psychiatric disorder and TDIU from September 6, 2011 to November 8, 2018.

The Board remands the claims for service connection for hypertension and a psychiatric disability, to include unspecified adjustment disorder, insomnia, anxiety, depression, and posttraumatic stress disorder (PTSD), as further development is needed.

The Board denied higher initial disability ratings for the service-connected psychiatric disability and denied earlier effective dates for TDIU, SMC at the schedular housebound rate, and DEA benefits.

The Board remands the claims for service connection for prostate cancer and an acquired psychiatric disorder due to new and relevant evidence being submitted.

The appeal is dismissed due to res judicata, as the issues were previously adjudicated and are now barred from further review.

The Board remands the claims for service connection for headaches and an acquired psychiatric disorder due to insufficient evidence.

The Board denied service connection for pneumonia and remanded the claims for iodine allergy, pilonidal cyst, sulfa allergy, heart disability, acquired psychiatric disorder, and lower and upper extremity disabilities.

The Board granted service connection for a back condition, neck condition, bilateral hearing loss, and an acquired psychiatric disorder, to include insomnia disorder. The claims for the remaining conditions were remanded.